Published: 19.07.2026 at 08:01 AM,
Editorial boerse-global.de
Plant-based substances from Traditional Chinese Medicine (TCM) assist with sleep disorders. A recent study confirms their potential—yet self-experiments with AI can end dangerously.
Researchers have confirmed the efficacy of TCM plants such as Ginseng, Poria, and Ziziphi Spinosae Semen. A review published in the journal Phytomedicine in June 2026 shows that these substances regulate neurotransmitters and hormones while positively affecting gut flora. This makes them a promising alternative to synthetic sleep aids—with significantly fewer side effects.
Cannabidiol (CBD) Pillowcases Against Shift Work Stress
In a surprising turn, a study conducted by China Medical University in July 2026 explored CBD-coated pillowcases. Among shift workers in healthcare, the PSQI score measuring sleep quality decreased, while levels of anxiety also saw a reduction.
AI Prescription Ends in Hospitalization
However, TCM is not a self-service solution. A case from Wuhan highlights the risks: a 25-year-old let an artificial intelligence generate an TCM recipe. The online-ordered ingredients resulted in severe heart palpitations and extreme sleep disturbances. The diagnosis revealed a Qi-blood disorder. The AI had prescribed cooling instead of the necessary warming agents. The patient only recovered after two months of correct treatment.
A Billion-Dollar Market for Sleep Disorders
The emerging TCM formula reduces wake-up time by 34%—completely free of side effects. A free report explains how you can benefit from this scientifically validated method. Request the report now
The market is booming: growing from $30.5 billion in 2025 to an estimated $78.6 billion by 2035. Eli Lilly acquired Centessa Pharmaceuticals in June 2026 for up to $7.8 billion, targeting orexin receptor agonists for narcolepsy and hypersomnia.
Moreover, Xi’an Tianfeng Bio-tech is launching a new product with the NF TriSolve Sleep Health Solution. In insomnia models, the formula reduced wake-up duration by 34% and positively influenced the gene expression of relevant receptors.
Stricter Controls for Herbal Remedies
Regulatory movements are also evident. In mid-July 2026, the European Parliament discussed a safety review for Ashwagandha by the EFSA. Singapore plans a mandatory reporting obligation for dietary supplements starting in 2028.
The industry is responding with mass spectrometry to ensure the purity and active ingredient content of TCM products, as customs authorities have repeatedly seized products without declared active substances in the past.
Caution is advised when considering AI-generated TCM recipes: the Wuhan case demonstrates the dangers of incorrect dosages. Our report provides a safety checklist and information on what to look for in TCM products. Secure the safety checklist now
Growing International Collaboration
In July 2026, China and Pakistan founded a joint TCM center aimed at export and standardization of traditional remedies. Both India and Indonesia have initiated their own campaigns to promote their herbal products worldwide.
Disclaimer regarding our articles: No investment advice, no buying or selling recommendations. Information on prices, companies, and markets is not guaranteed; changes may occur at any time. Stock market transactions can lead to significant losses. Our contributions are fully or partially automated with AI assistance.
en | science | 69801253 |

